Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
Oncolytic Virotherapy · 2018
DOI: 10.2147/ov.s155946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncolytic Virotherapy, 2018. Verfasst von Tien V Nguyen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Infectious Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Infectious Diseases.
- Virology and Gene Therapy Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences.
- Postbaccalaureate Research Education Program, Mayo Clinic Graduate School of Biomedical Sciences.
- Department of Immunology.
- Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.
Zitieren
APA
Nguyen, T. V., Crosby, C. M., Heller, G. J., Mendel, Z. I., Barry, M. E., & Barry, M. A. (2018). Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer. Oncolytic Virotherapy. https://doi.org/10.2147/ov.s155946
Vancouver
Nguyen TV, Crosby CM, Heller GJ, Mendel ZI, Barry ME, Barry MA. Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer. Oncolytic Virotherapy. 2018. doi:10.2147/ov.s155946
BibTeX
@article{Nguyen2018,
author = {Nguyen, Tien V and Crosby, Catherine M and Heller, Gregory J and Mendel, Zachary I and Barry, Mary E and Barry, Michael A},
title = {Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer},
journal = {Oncolytic Virotherapy},
year = {2018},
doi = {10.2147/ov.s155946}
}
EUVIMED